Lite Strategy, Inc.

Healthcare · Biotechnology · United States

Last price 1.17 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 35.58M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.